제약바이오 규제 전문 문헌 · 총 3,769건
General Considerations for the Use of New Approach Methodologies in Drug Development
Pyrogen and Endotoxins Testing: Questions and Answers: Guidance for Industry
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Medical Devices with Indications Associated with Weight Loss - Premarket Considerations: Guidance for Industry and Food and Drug Administration Staff
New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4): Draft Guidance for Industry
Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection
1–10 / 3,769건